Monday, March 25
Registration (07:30 – 17:00)

Welcome Coffee

Time: 07:30 – 08:15

Welcome and Keynote Presentation

Time : 08:15 – 09:00

Session 1: International Collaboration for Quality Results - Samples from Biobanks as Pacemaker for a Better Medicine

Time: 09:00 – 11:00

Coffee Break

Time: 11:00 – 11:30

Session 1: International Collaboration for Quality Results - Samples from Biobanks as Pacemaker for a Better Medicine

Time: 11:30 – 12:15

Networking Lunch

Time: 12:15 – 13:45

Session 2: Population-Based Biobanks: Learning from the Past & Targeting the Future

This session will focus on the role population based biobanks have contributed in understanding populations, genetic disorders as well as the effect of environmental changes on populations. It will highlight its accomplishments in the past and today as well as how to integrate knowledge translation methods in the future when discussing precision-care medicine.

Time: 13:45 – 16:00

Marianne Henderson, M.S. CPC, USA

Poster Session

Time: 16:00 – 17:00

Social Activity

Time: 17:00 – 20:00
Tuesday, March 26
Registration (07:30 – 16:30)

Welcome Coffee

Time: 07:30 – 08:15

Welcome and Opening Remarks

Time: 08:15 – 08:30

Keynote Presentation

Time: 08:30 – 19:15

Coffee Break

Time: 09:15 – 09:45

Session 3: A reach for Quality: Best Practices and Standards!

To increase the proportion of scientific research being conducted in a replicable and harmonized manner, efforts have been launched around the world to create standards and best practices. In 2018, ISBER released its 4th edition of the Best Practices for Repositories and continues to release the BPs in multiple languages to serve biobankers around the world. Also in 2018, the International Standards Organization (ISO) released a standard for biobanking (ISO 20387:2018), the result of several years of discussion of biobankers from all over the world. This session will describe the scope, need and implementation of best practices and standards in biobanking. A discussion of the opportunities and challenges of implementing BPs and standards will be included.

Time: 09:45 – 12:00


Daniel Simeon-Dubach, MD, MHA, Switzerland
Clare Alloca, USA
Zisis Kozlakidis, UK
Ms. Qafoud, Qatar
Andrea Wutte, Austria

Networking Lunch

Time: 12:00 – 13:30

Session 4: A Reach for Quality: Pre-Analytics as Key for Reproducibility

Pre-analytical variability of bio specimens can have significant effects on downstream analyses. Controlling such variables is fundamental for the future use of bio specimens in diagnostic or prognostic purposes. This session will cover pre-analytics research.
Time: 13:30 – 15:30

Poster Session

Time: 15:30 – 16:30

Social Activity

Time: 17:00 – 20:00
Wednesday, March 27
Registration (08:30 – 16:30)

Welcome Coffee

Time: 08:30 – 09:00

Session 5: Biobanks in Healthcare - From Basic Research to Clinical Use

Historically, even if bio specimens were operating on a smaller scale and at a local level, academic biobank have played major roles in the understanding and treatment of diseases such as cancer, HIV/AIDS and heart disease. Nonetheless, the process has increased the demand for high quality specimens that are reliable, accurate and highly annotated. In the era of precision care medicine, how are academic biobanks contributing to translational sciences? What are the different processes established in these biobanks to move from science to clinical application? Academia Disease Biobanks are strictly related to Healthcare practice and are a pillar for Personalized Medicine treatments. Recent technological developments (NGS) allow identification of genomic and transcriptomic alterations which are fundamental in Personalized treatments. This session will discuss the importance of disease biobanks to improve Healthcare practice.

Time: 08:30 – 10:20

Coffee Break

Time: 10:20 – 10:50

Session 6: Donors Matter: Incidental Findings & Return of Genetic Data

More and more of today’s large population studies, especially those that include genomic research, are grappling with whether to return research results and if so, the extent, mechanisms and challenges to return research results to study participants. The biospecimens and data from these studies may also yield information that is new and potentially clinically relevant to a participant who may not be aware of an incidental genomic finding. This session will include specific instances of return of results to participants from studies and biobanks around the world. The speakers will also touch on the procedures and ethical standards required to return research or genetic results as well as incidental findings during their talks and panel discussion.

Time: 10:50 – 13:10


Helena Judge Ellis, USA

Networking Lunch & Poster Session

Time: 13:10 – 14:10

Session 7: Opportunities and Challenges of Big Data and Artificial Intelligence in Medical Research

Time: 14:10 – 16:00

Awards and Closing Remarks

Time: 16:00 – 16:30

Abstract submission

We are welcoming the submission of abstracts for oral and/ or poster presentations under the below topics.

Quality Matters

pre-analytics for samples, biobank management, best practices and standards

Information Technology

IT tools, data sharing, big data, AI and data mining

Repository Management

workforce development, sustainability, biobank profiles, commercial biobanking

Ethical and Regulatory Issues

data sharing, patient engagement and empowerment, returning research results/ incidental findings, international collaboration

Biobanking in Healthcare

integrated biobanking, clinical trials, precision medicine

Collaboration and Partnerships

international collaborations, academic-industry partnerships, scientific-patient advocacy partnerships, regional biobank networks

Educational Tools

Hot Topics in Biobanking

innovative techniques and methods, emerging technologies




Feel free to reach out to us and request more information!

Contact us:

+32 (0)2 320 25 34

Contact Form